SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2008use that strong currency...... at least ONE company has vision.......scaram(o)uche-12/1/2005
2007Crucell buying Berna Biotech, headlines only at the moment. Been waiting for thscaram(o)uche-12/1/2005
2006MRK: 67.7B DNA: 102.6B AMGN:102.2B But, for now at least, PFE: 159.7BIan@SI-11/28/2005
2005Actually, I was joking about AMGN and DNA. Their MCs are now bigger than Merck&tuck-11/28/2005
2004Most of those are already betrothed. Medi jumps out however as mrk could avoikeokalani'nui-11/28/2005
2003GENZ? AMGN or DNA? Too big, although I suppose GENZ is a possibilty. PeterBiomaven-11/28/2005
2002<i>awkward fit with Vytorin</i> They are somewhat different marketsBiomaven-11/28/2005
2001<i>How about kosp?</i> Niaspan mono and KOSP’s planned Zocor+NiaspaDewDiligence_on_SI-11/28/2005
2000>>And isn't real cheap.<< When has that ever stopped a pharma?tuck-11/28/2005
1999sepr definitely fits. merck would have to give up the sleep drug they have in phrkrw-11/28/2005
1998Yes, CELG is a possibility, but it's a bit on the small side. And isn't Biomaven-11/28/2005
1997CELG? Cheers, Tucktuck-11/28/2005
1996<MRK> "Top-line growth" suggests only a tier-1/tier-2 biotech. Biomaven-11/28/2005
1995Let's see if the outside shareholders approve. The market reaction today sugBiomaven-11/28/2005
1994This relationship is what kept me from buying the stock when it was in the singlrkrw-11/28/2005
1993American Pharmaceutical Sets Deal By DAVID P. HAMILTON Staff Reporter of THE WDoc Bones-11/28/2005
1992So Cytel -----> Epimmune will live on as Pharmexa. Fell and then fell some mscaram(o)uche-11/27/2005
1991IDM to Sell Non-Core Assets To Pharmexa for $12 Million By a WALL STREET JOURNADoc Bones-11/27/2005
1990UK's Vernalis to buy Cita for up to $64.5 mln By Mark Potter LONDON, Nov 18nigel bates-11/18/2005
1989VNU and IMS Are Likely To Cancel Acquisition Pact By DENNIS K. BERMAN and JASONDoc Bones-11/17/2005
1988SkyePharma receives takeover approach, to review strategic options UPDATE LONDOnigel bates-11/14/2005
1987Barrons: Biotech Deals Get Pricey AFTER RECENTLY REPORTING ITS THIRD consecutivmopgcw-11/12/2005
1986apparently so... the market is certainly responding. ------------------------serendipity101-11/10/2005
1985Is OSI getting smart? yahoo.reuters.com JonRobohogs-11/10/2005
1984Serono Confirms Hiring Goldman Amid Sale Talks Swiss Biotech Firm Has Held DiscDoc Bones-11/9/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News